- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07629440
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS
The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumococcal vaccine that is currently in use, 20vPnC (Prevnar 20®).
This study will test if the new pneumococcal vaccine is as safe as the one that is currently in use. It will also assess how the new vaccine works in comparison to the one that is currently in use when given with other childhood vaccines.
To measure how the new pneumococcal vaccine compares to the current one, blood samples will be used to measure the body's ability to create proteins to fight those germs. This new vaccine can possibly provide additional protection against germs that cause pneumococcal disease that are not included in the vaccines that are currently given to infants. Pneumococcal disease includes a variety of infections caused by a specific germ, Streptococcus pneumoniae.
There are three groups in this study. All participants will be assigned to one of the three groups. This study is seeking participants who are:
- infants who are 2 months of age in Group 1;
- infants who are 2 to 6 months of age in Groups 2 and 3; and
- said to be healthy by the study doctor
About 3000 infants will be assigned to Group 1. The infants in this group will have a 1 in 2 chance (50%) of receiving either PG4 (new vaccine) or 20vPnC (currently in use) into the left thigh muscle at 2, 4, 6, and 12 to 15 months of age.
About 140 infants from outside the United States will be assigned to Group 2. The infants in this group will have a 1 in 2 chance (50%) of receiving either PG4 or 20vPnC into the left thigh muscle at 2 to 6, 3 to 8, 4 to 10, and 12 to 15 months of age.
About 90 infants from outside the United States will be assigned to Group 3. The infants in Group 3 will have a 1 in 3 chance (33%) of receiving either PG4 into the left thigh muscle, PG4 under the skin of the left thigh, or 20vPnC into the left thigh muscle at 2 to 6, 3 to 8, 4 to 10, and 12 to 15 months of age.
Infants in Group 1 will take part in this study for about 16 to 19 months (about 1 and a half years). Infants in Groups 2 and 3 will take part in this study for 12 to 21 months (about 1 to 1 and a half years). During this time, infants will have 6 study clinic visits and 1 phone call. At these study clinic visits, parent(s)/legal guardian(s) will be asked if the infant experienced any side effects. A side effect is an unintentional or unexpected reaction to a vaccine. Infants will have 3 blood samples collected.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Fase 3
Contactos e Locais
Contato de estudo
- Nome: Pfizer CT.gov Call Center
- Número de telefone: 1-800-718-1021
- E-mail: ClinicalTrials.gov_Inquiries@pfizer.com
Locais de estudo
-
-
Alabama
-
Bessemer, Alabama, Estados Unidos, 35022
- Ainda não está recrutando
- Kur Research, LLC
-
Birmingham, Alabama, Estados Unidos, 35233
- Recrutamento
- University of Alabama at Birmingham - School of Medicine
-
Birmingham, Alabama, Estados Unidos, 35205
- Recrutamento
- Alabama Clinical Therapeutics, LLC Birmingham Pediatric Associates
-
Centreville, Alabama, Estados Unidos, 35042
- Ainda não está recrutando
- Kur Research, LLC
-
-
Arkansas
-
Fayetteville, Arkansas, Estados Unidos, 72703
- Recrutamento
- Northwest Arkansas Pediatric Clinic
-
Jonesboro, Arkansas, Estados Unidos, 72401
- Recrutamento
- The Children's Clinic of Jonesboro, P.A.
-
Sherwood, Arkansas, Estados Unidos, 72120
- Recrutamento
- Helios Clinical Research
-
-
California
-
Anaheim, California, Estados Unidos, 92805
- Recrutamento
- Advanced Research Center, Inc.
-
Arcadia, California, Estados Unidos, 91007
- Recrutamento
- San Gabriel Woman's Health
-
Bellflower, California, Estados Unidos, 90706
- Recrutamento
- Coast Clinical Research, LLC
-
El Monte, California, Estados Unidos, 91731
- Recrutamento
- Family Medical Clinic
-
Fresno, California, Estados Unidos, 93704
- Recrutamento
- Clinical Research of Central California
-
Montebello, California, Estados Unidos, 90640
- Recrutamento
- SeraCollection Research Services, LLC
-
National City, California, Estados Unidos, 91950
- Recrutamento
- Bailony Pediatrics
-
Palo Alto, California, Estados Unidos, 94304
- Ainda não está recrutando
- Stanford University Medical Center
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80045
- Recrutamento
- Childrens Hospital of Colorado
-
-
Florida
-
Hialeah, Florida, Estados Unidos, 33012
- Recrutamento
- Direct Helpers Research Center
-
Homestead, Florida, Estados Unidos, 33030
- Recrutamento
- C & R Research Services USA
-
Miami, Florida, Estados Unidos, 33155
- Recrutamento
- Gold Coast Health Research Center, LLC
-
Miami, Florida, Estados Unidos, 33155
- Recrutamento
- Bioresearch Partner
-
Miami, Florida, Estados Unidos, 33143
- Recrutamento
- Florida Pharmaceutical Research and Associates, Inc.
-
Miami, Florida, Estados Unidos, 33173
- Recrutamento
- Dade Research Center
-
Miami, Florida, Estados Unidos, 33183
- Recrutamento
- Vasconcello-Cohen MD Research, LLC.
-
Miami Lakes, Florida, Estados Unidos, 33014
- Recrutamento
- Riveldi and Associates
-
North Lauderdale, Florida, Estados Unidos, 33068
- Recrutamento
- Eminent Clinical Research and Associates
-
Sweetwater, Florida, Estados Unidos, 33182
- Recrutamento
- Cordova Research Institute LLC
-
Tampa, Florida, Estados Unidos, 33617
- Recrutamento
- Children's Health Center
-
-
Georgia
-
Chamblee, Georgia, Estados Unidos, 30341
- Ainda não está recrutando
- ObjectiveHealth Clinical Research LLC - Chamblee
-
Norcross, Georgia, Estados Unidos, 30093
- Recrutamento
- Altruistic Clinical Research Global
-
-
Idaho
-
Ammon, Idaho, Estados Unidos, 83406
- Recrutamento
- Medical Research Partners
-
Blackfoot, Idaho, Estados Unidos, 83221
- Recrutamento
- Bingham Memorial Hospital
-
Boise, Idaho, Estados Unidos, 83702
- Recrutamento
- ASR, LLC
-
Idaho Falls, Idaho, Estados Unidos, 83404
- Recrutamento
- Leavitt Clinical Research
-
-
Illinois
-
Moline, Illinois, Estados Unidos, 61265
- Recrutamento
- MidValley Research, Inc
-
-
Iowa
-
Ankeny, Iowa, Estados Unidos, 50023
- Recrutamento
- The Iowa Clinic.
-
West Des Moines, Iowa, Estados Unidos, 50265
- Recrutamento
- Eximia Research - IA, LLC (dba Integrated Clinical Trial Services, LLC)
-
-
Kansas
-
Derby, Kansas, Estados Unidos, 67037
- Recrutamento
- Integrity Clinical Network, LLC
-
-
Louisiana
-
Haughton, Louisiana, Estados Unidos, 71037
- Recrutamento
- ACC Pediatric Research
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- Ainda não está recrutando
- University of Maryland, Baltimore, Center for Vaccine Development and Global Health
-
Columbia, Maryland, Estados Unidos, 21045
- Ainda não está recrutando
- The Pediatric Center
-
Columbia, Maryland, Estados Unidos, 21045
- Recrutamento
- Kur Research, LLC
-
-
Michigan
-
Allen Park, Michigan, Estados Unidos, 48101
- Recrutamento
- Michigan Institute of Research
-
Bingham Farms, Michigan, Estados Unidos, 48025
- Recrutamento
- Michigan Center of Medical Research
-
Dearborn Heights, Michigan, Estados Unidos, 48127
- Recrutamento
- Vida Clinical Studies, LLC
-
-
Missouri
-
Columbia, Missouri, Estados Unidos, 65212
- Recrutamento
- University of Missouri
-
Columbia, Missouri, Estados Unidos, 65201
- Recrutamento
- University of Missouri Pediatrics Clinic-South Providence
-
-
Nebraska
-
Grand Island, Nebraska, Estados Unidos, 68803
- Recrutamento
- Velocity Clinical Research, Grand Island
-
Lincoln, Nebraska, Estados Unidos, 68504
- Recrutamento
- Midwest Children's Health Research Institute
-
Lincoln, Nebraska, Estados Unidos, 68505
- Recrutamento
- Midwest Children's Health Research Institute
-
Lincoln, Nebraska, Estados Unidos, 68516
- Recrutamento
- Midwest Children's Health Research Institute
-
Lincoln, Nebraska, Estados Unidos, 68522
- Recrutamento
- Midwest Children's Health Research Institute
-
-
New York
-
East Syracuse, New York, Estados Unidos, 13057
- Recrutamento
- Child Health Care Associates
-
Rochester, New York, Estados Unidos, 14642
- Recrutamento
- University of Rochester Medical Center
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28203
- Recrutamento
- Atrium Health Cannon Research Cente
-
Charlotte, North Carolina, Estados Unidos, 28207
- Recrutamento
- Atrium Health - STRIVE Research clinic
-
Charlotte, North Carolina, Estados Unidos, 28207
- Recrutamento
- Atrium Health Levine Children's Myers Park Pediatrics
-
Durham, North Carolina, Estados Unidos, 27703
- Recrutamento
- Duke Vaccine and Trials Unit
-
Durham, North Carolina, Estados Unidos, 27704
- Recrutamento
- Durham Pediatrics at North Duke Street
-
Matthews, North Carolina, Estados Unidos, 28105
- Recrutamento
- Atrium Health Levine Children's Charlotte Pediatrics
-
Matthews, North Carolina, Estados Unidos, 28105
- Recrutamento
- Atrium Health STRIVE Research Clinic - Matthews
-
Wilmington, North Carolina, Estados Unidos, 28405
- Recrutamento
- Wilmington Health
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45245
- Recrutamento
- Pediatric Associates of Mt. Carmel
-
Dayton, Ohio, Estados Unidos, 45429
- Recrutamento
- PriMed Clinical Research
-
South Euclid, Ohio, Estados Unidos, 44121
- Recrutamento
- Senders Pediatrics
-
-
Pennsylvania
-
Bellevue, Pennsylvania, Estados Unidos, 15202
- Recrutamento
- UPMC Children's Community Pediatrics- Bellevue
-
Cranberry Township, Pennsylvania, Estados Unidos, 16066
- Recrutamento
- UPMC Children's Community Pediatrics Bass Wolfson-Cranberry
-
Erie, Pennsylvania, Estados Unidos, 16506
- Recrutamento
- Allegheny Health and Wellness Pavilion
-
Jefferson Hills, Pennsylvania, Estados Unidos, 15025
- Recrutamento
- UPMC Children's Community Pediatrics South Hills-Jefferson Hills
-
N. Huntingdon, Pennsylvania, Estados Unidos, 15642
- Recrutamento
- UPMC Children's Community Pediatrics - Norwin
-
Pittsburgh, Pennsylvania, Estados Unidos, 15217
- Recrutamento
- UPMC Children's Community Pediatrics Bass Wolfson-Squirrel Hill
-
Pittsburgh, Pennsylvania, Estados Unidos, 15234
- Recrutamento
- UPMC Children's Community Pediatrics-Castle Shannon
-
Pittsburgh, Pennsylvania, Estados Unidos, 15213
- Recrutamento
- UPMC Children's Hospital of Pittsburgh Primary Care Center-Oakland
-
Pittsburgh, Pennsylvania, Estados Unidos, 15227
- Recrutamento
- UPMC Children's Community Pediatrics-Brentwood
-
-
South Carolina
-
Simpsonville, South Carolina, Estados Unidos, 29680
- Recrutamento
- Tribe Clinical Research LLC. at Parkside Pediatrics Harrison Bridge Road
-
Summerville, South Carolina, Estados Unidos, 29486
- Recrutamento
- Carolina Family Care
-
Summerville, South Carolina, Estados Unidos, 29486
- Recrutamento
- MUSC Children's Health
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38105
- Ainda não está recrutando
- Le Bonheur Children's Hospital - Outpatient Building
-
Tullahoma, Tennessee, Estados Unidos, 37388
- Recrutamento
- Pediatric Clinical Trials of Tennessee, LLC
-
-
Texas
-
Brownsville, Texas, Estados Unidos, 78520
- Recrutamento
- Proactive RGV
-
Corpus Christi, Texas, Estados Unidos, 78404
- Ainda não está recrutando
- South Texas Clinical Research
-
Edinburg, Texas, Estados Unidos, 78539
- Recrutamento
- Proactive Clinical Research LLC
-
El Paso, Texas, Estados Unidos, 79902
- Recrutamento
- Proactive El Paso,LLC
-
Forney, Texas, Estados Unidos, 75126
- Recrutamento
- SMS Clinical Research LLC.
-
Galveston, Texas, Estados Unidos, 77555
- Recrutamento
- University of Texas Medical Branch, Sealy Institute for Vaccine Sciences Clinical Trials Program
-
Houston, Texas, Estados Unidos, 77065
- Recrutamento
- Kool Kids Pediatrics
-
Houston, Texas, Estados Unidos, 77090
- Recrutamento
- Houston Clinical Research Associates
-
Houston, Texas, Estados Unidos, 77054
- Recrutamento
- Mercury Clinical Research (Administrative Office)
-
Houston, Texas, Estados Unidos, 77077
- Recrutamento
- Mercury Clinical Research - Sunrise Pediatrics
-
Houston, Texas, Estados Unidos, 77042
- Recrutamento
- Neutra Life Sciences
-
Houston, Texas, Estados Unidos, 77087
- Recrutamento
- Mercury Clinical Research - MD Kids Pediatrics
-
Houston, Texas, Estados Unidos, 77057
- Ainda não está recrutando
- UDL Clinical Research, LLC.
-
Houston, Texas, Estados Unidos, 77074
- Recrutamento
- Aavon Clinical Trials, LLC.
-
Houston, Texas, Estados Unidos, 77074
- Recrutamento
- RTX Clinical Research
-
Lewisville, Texas, Estados Unidos, 75067
- Recrutamento
- Prime Clinical Research - Lewisville
-
Mansfield, Texas, Estados Unidos, 76063
- Recrutamento
- Prime Clinical Research - Mansfield
-
McAllen, Texas, Estados Unidos, 78504
- Recrutamento
- Dr. Ruben Aleman & Associates
-
Mesquite, Texas, Estados Unidos, 75149
- Recrutamento
- SMS Clinical Research LLC
-
Mesquite, Texas, Estados Unidos, 75150
- Recrutamento
- SMS Clinical Research LLC
-
Richmond, Texas, Estados Unidos, 77469
- Recrutamento
- Pediatric Center- Neutra Life Sciences
-
San Antonio, Texas, Estados Unidos, 78215
- Recrutamento
- Sun Research Institute
-
Victoria, Texas, Estados Unidos, 77901
- Ainda não está recrutando
- Crossroads Clinical Research
-
-
Utah
-
Provo, Utah, Estados Unidos, 84604
- Recrutamento
- AMR Clinical
-
Syracuse, Utah, Estados Unidos, 84075
- Recrutamento
- AMR Clinical
-
-
Virginia
-
Richmond, Virginia, Estados Unidos, 23226
- Recrutamento
- Clinical Research Partners, LLC
-
Richmond, Virginia, Estados Unidos, 23233
- Recrutamento
- Tekton Research, LLC.
-
-
Wisconsin
-
Marshfield, Wisconsin, Estados Unidos, 54449
- Recrutamento
- Marshfield Medical Center - Marshfield
-
-
-
-
-
Fukui, Japão, 910-0833
- Recrutamento
- Fukui Aiiku Hospital
-
Fukuoka, Japão, 813-0036
- Recrutamento
- Fukazawa Pediatric Clinic
-
Osaka, Japão, 544-0033
- Recrutamento
- Kubota Children's Clinic
-
-
Aichi-ken
-
Toyota-shi, Aichi-ken, Japão, 471-8513
- Recrutamento
- Toyota Memorial Hospital
-
-
Fukuoka
-
Fukuoka, Fukuoka, Japão, 814-0121
- Recrutamento
- Shindo children's clinic
-
Kasuga, Fukuoka, Japão, 816-0801
- Recrutamento
- Yokoyama Children'S Clinic
-
-
Hokkaido
-
Sapporo, Hokkaido, Japão, 062-0907
- Recrutamento
- Ohigesenseino Kodomo Clinic
-
-
Kagoshima-ken
-
Hioki, Kagoshima-ken, Japão, 899-2503
- Recrutamento
- Nintenkaikagoshima Children's Hospital
-
-
Tokyo
-
Shinjuku-ku, Tokyo, Japão, 160-0017
- Recrutamento
- Futaba Clinic
-
-
Yamanashi
-
Kofu, Yamanashi, Japão, 400-0853
- Recrutamento
- Kose Children Clinic
-
-
-
-
-
Bayamón, Porto Rico, 00960
- Recrutamento
- Clinical Research Investigator Group
-
Caguas, Porto Rico, 00726
- Recrutamento
- San Juan Bautista School of Medicine - Clinical Research Unit
-
Caguas, Porto Rico, 00725
- Recrutamento
- Caguas Clinical Research
-
Guayama, Porto Rico, 00784
- Recrutamento
- Clinical Research Puerto Rico
-
Ponce, Porto Rico, 00716
- Recrutamento
- Ponce Medical School Foundation Inc./ CAIMED Center
-
Ponce, Porto Rico, 00728
- Recrutamento
- BRCR Global Puerto Rico
-
San Juan, Porto Rico, 00907
- Recrutamento
- BRCR Global Puerto Rico
-
Trujillo Alto, Porto Rico, 00976-3910
- Recrutamento
- San Miguel Medical
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- infants who are 2 months of age in Group 1.
- infants who are 2 to 6 months of age in Groups 2 and 3.
- Healthy infants determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study.
Exclusion Criteria:
- History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis).
- Major known congenital malformation or serious chronic disorder.
- Other acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the participant inappropriate for entry into this study.
- Previous vaccination with any licensed or investigational pneumococcal vaccine, or planned receipt through study participation.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Group 1 PG4 (intramuscular)
Multivalent Pneumococcal Vaccine
|
Multivalent Pneumococcal Vaccine
|
|
Comparador Ativo: Group 1 20-valent pneumococcal conjugate vaccine (20vPnC) (intramuscular)
20-valent pneumococcal conjugate vaccine (20vPnC)
|
Vacina pneumocócica 20-valente conjugada (20vPnC)
Outros nomes:
|
|
Experimental: Group 2 PG4 (intramuscular)
Multivalent Pneumococcal Vaccine
|
Multivalent Pneumococcal Vaccine
|
|
Comparador Ativo: Group 2 20-valent pneumococcal conjugate vaccine (20vPnC) (intramuscular)
20-valent pneumococcal conjugate vaccine (20vPnC)
|
Vacina pneumocócica 20-valente conjugada (20vPnC)
Outros nomes:
|
|
Experimental: Group 3 PG4 (intramuscular)
Multivalent Pneumococcal Vaccine
|
Multivalent Pneumococcal Vaccine
|
|
Experimental: Group 3 PG4 (subcutaneous)
Multivalent Pneumococcal Vaccine
|
Multivalent Pneumococcal Vaccine
|
|
Comparador Ativo: Group 3 20-valent pneumococcal conjugate vaccine (20vPnC) (intramuscular)
20-valent pneumococcal conjugate vaccine (20vPnC)
|
Vacina pneumocócica 20-valente conjugada (20vPnC)
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Porcentagem de participantes que relataram reações locais nos 7 dias após cada dose
Prazo: Dia 7
|
Reações locais solicitadas após cada dose
|
Dia 7
|
|
Porcentagem de participantes que relataram eventos adversos graves (EAGs)
Prazo: Dose 1 a 6 meses após a Dose 4
|
EAGs ocorrendo da Dose 1 a 6 meses após a Dose 4
|
Dose 1 a 6 meses após a Dose 4
|
|
Percentage of participants reporting systemic events within 7 days after each dose
Prazo: Day 7
|
Prompted systemic events after each dose
|
Day 7
|
|
Percentage of participants reporting adverse events (AEs) from Dose 1 to 1 month after Dose 3
Prazo: Dose 1 to 1 month after Dose 3
|
AEs occurring from Dose 1 to 1 month after Dose 3
|
Dose 1 to 1 month after Dose 3
|
|
Percentage of participants reporting AEs from Dose 4 to 1 month after Dose 4
Prazo: Dose 4 to 1 month after Dose 4
|
AEs occurring from Dose 4 to 1 month after Dose 4
|
Dose 4 to 1 month after Dose 4
|
|
Differences in percentages of participants with predefined pneumococcal specific immunoglobulin G (IgG) concentrations 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Differences in pneumococcal immunoglobulin G (IgG) concentrations 1 month after Dose 3
|
1 month after Dose 3
|
|
Pneumococcal IgG geometric mean concentrations (GMCs) 1 month after Dose 4
Prazo: 1 month after Dose 4
|
Pneumococcal IgG GMCs 1 month after Dose 4
|
1 month after Dose 4
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pneumococcal IgG GMCs 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Pneumococcal IgG GMCs 1 month after Dose 3
|
1 month after Dose 3
|
|
Percentage of participants with serotype 3 specific predefined pneumococcal IgG concentrations 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Pneumococcal serotype 3 IgG concentrations 1 month after Dose 3
|
1 month after Dose 3
|
|
Pneumococcal serotype 3 IgG GMCs 1 month after Dose 4
Prazo: 1 month after Dose 4
|
Pneumococcal serotype 3 IgG GMCs 1 month after Dose 4
|
1 month after Dose 4
|
|
Differences in percentages of participants with predefined pneumococcal serotype 6C and 15C immunoglobulin G (IgG) concentrations 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Differences in pneumococcal serotype 6C and 15C immunoglobulin G (IgG) concentrations 1 month after Dose 3
|
1 month after Dose 3
|
|
Pneumococcal serotype 6C and 15C IgG GMCs and GMRs 1 month after Dose 4
Prazo: 1 month after Dose 4
|
Pneumococcal serotype 6C and 15C IgG GMCs and GMRs 1 month after Dose 4
|
1 month after Dose 4
|
|
Pneumococcal opsonophagocytic activity (OPA) titers 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Pneumococcal OPA titers 1 month after Dose 3
|
1 month after Dose 3
|
|
Pneumococcal OPA titers prior to Dose 4
Prazo: Prior to Dose 4
|
Pneumococcal OPA titers prior to Dose 4
|
Prior to Dose 4
|
|
Pneumococcal OPA titers 1 month after Dose 4
Prazo: 1 month after Dose 4
|
Pneumococcal OPA titers 1 month after Dose 4
|
1 month after Dose 4
|
|
Percentage of participants with predefined pneumococcal specific IgG concentrations 1 month after Dose 4
Prazo: 1 month after Dose 4
|
Percentage of participants with predefined pneumococcal specific IgG concentrations 1 month after Dose 4
|
1 month after Dose 4
|
|
Pneumococcal IgG concentrations 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Pneumococcal IgG concentrations 1 month after Dose 3
|
1 month after Dose 3
|
|
Pneumococcal IgG concentrations prior to Dose 4
Prazo: Prior to Dose 4
|
Pneumococcal IgG concentrations prior to Dose 4
|
Prior to Dose 4
|
|
Pneumococcal IgG concentrations 1 month after Dose 4
Prazo: 1 month after Dose 4
|
Pneumococcal IgG concentrations 1 month after Dose 4
|
1 month after Dose 4
|
|
IgG geometric mean fold rise (GMFR) from before Dose 4 to 1 month after Dose 4
Prazo: Before Dose 4 to 1 month after Dose 4
|
IgG GMFR from before Dose 4 to 1 month after Dose 4
|
Before Dose 4 to 1 month after Dose 4
|
|
IgG GMFR from 1 month after Dose 3 to 1 month after Dose 4
Prazo: From 1 month after Dose 3 to 1 month after Dose 4
|
IgG GMFR from 1 month after Dose 3 to 1 month after Dose 4
|
From 1 month after Dose 3 to 1 month after Dose 4
|
|
Percentages of participants with prespecified antibody levels to specific concomitant vaccine antigens 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Prespecified antibody levels to specific concomitant vaccine antigens 1 month after Dose 3
|
1 month after Dose 3
|
|
Geometric mean of antibody levels to measles, mumps, rubella, varicella, and hepatitis A virus antigens 1 month after Dose 4
Prazo: 1 month after Dose 4
|
Geometric mean of antibody levels to measles, mumps, rubella, varicella, and hepatitis A virus antigens 1 month after Dose 4
|
1 month after Dose 4
|
|
Geometric mean of immunoglobulin A (IgA) antibody levels to rotavirus 1 month after Dose 3
Prazo: 1 month after Dose 3
|
Geometric mean of IgA antibody levels to rotavirus 1 month after Dose 3
|
1 month after Dose 3
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Pfizer CT.gov Call Center, Pfizer
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- C4931008
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .